No Data
Tracking of Hong Kong stock concepts | The Medical Insurance Bureau has announced the new medical insurance catalog. Institutions believe that the golden opportunity to increase the allocation of the pharmaceutical sector has already opened (including con
The National Medical Insurance Bureau has conducted preliminary reviews on 440 pharmaceuticals for this year's medical insurance catalog, which is an increase from last year.
Guolian Securities: Increased attention to tumor immunology, recommend focusing on targeted drugs such as PD1/IL2 in pharmaceutical companies.
With the increasing attention to tumor immunity, and the successive launch of advantageous products, bullish on PD1/IL2 and PD1/IL15 targeted drugs.
Express News | Silo Pharma Shares Are Trading Higher After the Company Entered Into an Agreement With WuXi AppTec for a Preclinical Small Animal Study of SPU-16
Express News | Silo Pharma Inc - Enters Agreement With WuXi AppTec for Spu-16 Study
Hang Seng Index: Benefiting from policy support, biotechnology stocks have seen three consecutive months of inflows.
The Hang Seng Index company stated that there are signs of improvement in the recent situation of biotechnology stocks, as well as benefitting from policy support and three consecutive months of inflow of funds.
Breaking News: Contract research organizations are all on the rise, with Genscript Bio Technology leading the way with a 7.56% increase and WuXi AppTec with a 5.57% increase.
On August 6th, CXO concept stocks rose across the board. As of press time, Genscript Bio (01548.HK) rose 7.56% to HKD 12.8; Wuxi Apptec (02359.HK) rose 5.57% to HKD 35.05; Pharmaron (03759.HK) rose 3.64% to HKD 9.96; Wuxi Bio (02269.HK) rose 3.06% to HKD 11.44. The market source is from Futubull. On the news front, on August 6th, Daly of the Federal Reserve stated that the economy has been slowing down for the past few months; regarding the upcoming meeting in September.
No Data
